Danny Rischin MD Of Peter MacCallum Cancer Centre Discusses KEYNOTE-48 Trial Implications: Will Provide An Opportunity For Patients To Have Treatment In First Line.
KEYNOTE-48 Trial Implications: Will Provide An Opportunity For Patients To Have Treatment In First Line
By Editor